CAOS Causes Robotic Revival in Orthopedics

It has been nearly a decade since the promise of medical robotics, first unveiled in orthopedic surgery, was introduced with the launch of the Robodoc surgical system. But robotics and other computer-assisted tools such as navigation systems failed to live up to their early hype, and surgeons were slow to adopt the new technology. However, according to presentations made at this year's American Academy of Orthopaedic Surgeons (AAOS) meeting, held in February in Dallas, improved technology appears to be generating increased interest among orthopedic surgeons in robotics, navigation systems, and other computer-assisted tools, resulting in the emergence of a new sub-specialty called computer-assisted orthopedic surgery (CAOS).

It has been nearly a decade since the promise of medical robotics, first unveiled in orthopedic surgery, was introduced with the launch of the Robodoc surgical system by Integrated Surgical Systems Inc. to perform a total hip arthroplasty. But robotics and other computer-assisted tools such as navigation systems failed to live up to their early hype, and surgeons were slow to adopt the new technology. This occurred in part because the early systems took surgery out of the surgeons' hands, and in part because the early generation technologies were clunky and required doctors to significantly alter their established surgical routines.

But could interest in robotics, and in particular orthopedic applications, be making a comeback? According to presentations at this year's American Academy of Orthopaedic Surgeons (AAOS) meeting, held in February...

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By 

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.

Cardiosense Advances Noninvasive Heart Monitoring With Final Validation Study

 
• By 

Cardiosense has launched a nationwide clinical study, SEISMIC-HF II, to validate its non-invasive, AI-powered technology for monitoring heart failure. The data will be used to file for US regulatory clearance of the Cardiosense heart failure monitoring platform.

ConcertAI Launches Generative AI-Powered Precision Suite

 

Valued at over $1.9bn, ConcertAI is building on its pre-existing multi-agentic AI SaaS solution CARAai to bring life science customers the new Precision suite of applications: Precision Explorer, Precision Trials, Precision GTM and Precision360.